Nexalin Technology (NXL) Research & Development (2024 - 2026)
Nexalin Technology's Research & Development came in at $564,480 for Q2 2026, up 150.0% from $225,774 a year earlier and up 63.0% from the prior quarter.
Powered by 
Analysis
Nexalin Technology (NXL) Research & Development (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Nexalin Technology reported Research & Development of $1.36 million, down 12.0% year-over-year; for FY2025, it was $1.08 million, down 9.0% from FY2024.
- Going back by year, Research & Development was $1.19 million in FY2024 (-38.0%) and $1.92 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Research & Development since Q4 2024.
- Year-over-year, Research & Development increased in four of the last six quarters, with growth averaging 68.4%.
- Business Quant data shows NXL's Research & Development at $346,382 (Q1 2026), $224,940 (Q4 2025) and $226,520 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 364.00 Mn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 892.00 Mn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 412.00 Mn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 370.60 Mn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 771.00 Mn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 434.00 Mn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 554.00 Mn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 278.90 Mn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 258.00 Mn |
| 10 | Nexalin Technology | 3.09 Mn | -8.70 Mn | 8,897.00 | 564,480.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 564,480.00 |
| Mar 31, 2026 | 346,382.00 |
| Dec 31, 2025 | 224,940.00 |
| Sep 30, 2025 | 226,520.00 |
| Jun 30, 2025 | 225,774.00 |
| Mar 31, 2025 | 406,288.00 |
| Dec 31, 2024 | 737,242.00 |
| Sep 30, 2024 | 178,565.00 |
| Jun 30, 2024 | 169,410.00 |
| Mar 31, 2024 | 105,668.00 |
API Access
Nexalin Technology Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();